XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) EPS (Diluted) (2017 - 2026)

Updated

XBiotech (XBIT) posted EPS (Diluted) of -$0.22 for Q2 2026, compared with -$0.06 a year earlier.

Analysis

XBiotech (XBIT) EPS (Diluted) (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at XBiotech was -$1.36; for FY2025, it was -$1.49.

  • In prior years, XBiotech's EPS (Diluted) was -$1.26 in FY2024, -$0.81 in FY2023, -$1.08 in FY2022 and -$0.58 in FY2021.
  • Quarterly EPS (Diluted) has run from a low of -$0.88 in Q4 2025 to a high of -$0.06 in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 7.22
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.09
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 2.38
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.04
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 2.00
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 7.08
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.94
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 0.56
10 XBiotech 58.23 Mn -439.75 Mn - -0.22
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.22
Dec 31, 2025 -0.88
Sep 30, 2025 -0.20
Jun 30, 2025 -0.06
Mar 31, 2025 -0.36
Dec 31, 2024 -0.34
Sep 30, 2024 -0.16
Jun 30, 2024 -0.43
Mar 31, 2024 -0.33
Dec 31, 2023 -0.15
Sep 30, 2023 -0.24
Jun 30, 2023 -0.29
Mar 31, 2023 -0.13
Dec 31, 2022 -0.11
Sep 30, 2022 -0.42
Jun 30, 2022 -0.39
Mar 31, 2022 -0.18
Dec 31, 2021 -0.22
Sep 30, 2021 -0.11
Jun 30, 2021 -0.17
API Access

XBiotech EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=XBIT&period=max&api_key=YOUR_API_KEY